Cargando…

DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways

BACKGROUND: The B-cell lymphoma 6 (BCL6) oncogene is required for the survival of diffuse large B-cell lymphoma (DLBCL), which is incurable using conventional chemotherapy. Thus, it is imperative to improve the survival of patients with DLBCL. Disulfide (DSF) has been shown to have anticancer effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yunying, Lei, Chenshuang, Jiang, Qian, Yu, Qinhua, Qiu, Liannv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317061/ https://www.ncbi.nlm.nih.gov/pubmed/35883106 http://dx.doi.org/10.1186/s12935-022-02661-4

Ejemplares similares

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer
por: Li, Zequn, et al.
Publicado: (2020)

Cutaneous plaque in adult T cell leukemia/lymphoma: A case report
por: Lei, Chen Shuang, et al.
Publicado: (2020)

Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2013)

Suppression of the NF-κB co-factor, Bcl3, delays the metastatic progression of breast cancer
por: Wakefield, AM, et al.
Publicado: (2010)

The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice
por: Liu, C, et al.
Publicado: (2015)

Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer
por: Pan, Wenfei, et al.
Publicado: (2022)

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
por: Liu, Qinhua, et al.
Publicado: (2022)

NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
por: Pasqualucci, Laura, et al.
Publicado: (2022)

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
por: Kim, Eunju, et al.
Publicado: (2022)

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
por: Zhang, Mingzhi, et al.
Publicado: (2016)

Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
por: Bognar, M K, et al.
Publicado: (2016)

Bonding Cables in DSF Cleanroom 186
por: Ordan, Julien Marius
Publicado: (2018)

Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2019)

Suppression of NF-κB Reduces Myocardial No-Reflow
por: Zeng, Min, et al.
Publicado: (2012)

Several Alphaherpesviruses Interact Similarly with the NF-κB Pathway and Suppress NF-κB-Dependent Gene Expression
por: Romero, Nicolás, et al.
Publicado: (2023)

Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM/NF-κB signaling
por: Che, Yilin, et al.
Publicado: (2018)

The natural flavonoid glycoside vitexin displays preclinical antitumor activity by suppressing NF-κB signaling in nasopharyngeal carcinoma
por: Wang, Wenbin, et al.
Publicado: (2019)

Structural basis of DSF recognition by its receptor RpfR and its regulatory interaction with the DSF synthase RpfF
por: Waldron, Evan J., et al.
Publicado: (2019)

Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice
por: Shukla, Sanjeev, et al.
Publicado: (2015)

Constitutive NF-κB Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma
por: Turturro, Francesco
Publicado: (2015)

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study
por: Faumont, Nathalie, et al.
Publicado: (2021)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification
por: Miyaoka, Masashi, et al.
Publicado: (2022)

Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
por: Wakefield, A, et al.
Publicado: (2008)

Primary cutaneous diffuse large B‐cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression
por: Okada, Yosuke, et al.
Publicado: (2021)

Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas
por: Pinkney, Kerice A., et al.
Publicado: (2015)

Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
por: Wawire, Jonathan, et al.
Publicado: (2019)

Xanthomonas campestris cell–cell signalling molecule DSF (diffusible signal factor) elicits innate immunity in plants and is suppressed by the exopolysaccharide xanthan
por: Kakkar, Akanksha, et al.
Publicado: (2015)

NF-κB inducing kinase maintains T cell metabolic fitness in antitumor immunity
por: Gu, Meidi, et al.
Publicado: (2021)

Functionally impaired follicular helper T cells induce regulatory B cells and CD14(+) human leukocyte antigen‐DR (−) cell differentiation in non‐small cell lung cancer
por: Qiu, Liannv, et al.
Publicado: (2018)

Procyanidin B2 inhibits lipopolysaccharide-induced apoptosis by suppressing the Bcl-2/Bax and NF-κB signalling pathways in human umbilical vein endothelial cells
por: Song, Da-Qiang, et al.
Publicado: (2021)

Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1 and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines
por: Ren, Li, et al.
Publicado: (2018)

Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-κB Activity and Regulating Bax/Bcl-2 Expression
por: Zhang, Shuaishuai, et al.
Publicado: (2016)

Unkeito Suppresses RANKL-Mediated Osteoclastogenesis via the Blimp1–Bcl6 and NF-κB Signaling Pathways and Enhancing Osteoclast Apoptosis
por: Fang, Ke, et al.
Publicado: (2022)

Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period
por: Savlı, Hakan, et al.
Publicado: (2016)

Probiotic DSF counteracts chemotherapy induced neuropathic pain
por: Castelli, Vanessa, et al.
Publicado: (2018)

Tear nanoDSF Denaturation Profile Is Predictive of Glaucoma
por: Baksheeva, Viktoriia E., et al.
Publicado: (2023)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

MEF2B mutations lead to deregulated expression of the BCL6 oncogene in Diffuse Large B cell Lymphoma
por: Ying, Carol Y., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9oosb9pj52hudtere68d555m6k